MacroGenics sells GMP manufacturing operations to Bora Pharma for $122.5M upfront

MACROGENICS INC

Bora pays $122.5M cash at closing for MacroGenics' CDMO business, including Rockville site (11,000 L capacity) and Frederick warehouse.
Up to $5M in additional milestone payments to MacroGenics based on 2027-2028 CDMO manufacturing and professional development services.
Approximately 140 MacroGenics employees expected to be hired by Bora; transaction expected to close in Q3 2026.
MacroGenics will enter supply and transition services agreements to retain clinical manufacturing support for its pipeline.
Transaction approved by both boards; subject to customary closing conditions and consents.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MACROGENICS INC entered into Asset Purchase Agreement with Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC valued at $122.5 million in cash (effective 2026-05-11).

Action: entry
Agreement: asset purchase
Counterparty: Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC
Value: $122.5 million in cash
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, MacroGenics, Inc., a Delaware corporation (the "Company"), entered into an Asset Purchase Agreement (the "Purchase Agreement") with Bora Pharmaceuticals Co., Ltd., a company organized under the laws of Taiwan ("Bora"), and Bora Biologics USA, LLC, a Delaware limited liability company (collectively, the "Purchaser"), pursuant to which the Company agreed to sell to the Purchaser assets and current liabilities related to its GMP manufacturing operations, including its CDMO business (the "CDMO Operations") currently conducted by the Company at its manufacturing facility located at 9704 Medical Center Drive, Rockville, Maryland and related warehouse operations located at 4735 Arcadia Drive, Frederick, Maryland (excluding all research and related assets and operations of the Company) (the "Transaction").

View on SEC.gov

301 material agreements filed in the last 30 days. Browse all material agreements →

MACROGENICS INC filing history →

Source: SEC EDGAR

accession 0001125345-26-000035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.